Home
Zydus Lifesciences Limited
Press Release Aug 30 2024
Business
Aug 30 2024
4 min read

Press Release Aug 30 2024

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 30, 2024, titled "Zydus receives final approval from USFDA for Scopolamine Transdermal System 1 mg/3 days".

View Attachment